InvestorsHub Logo
Followers 7
Posts 996
Boards Moderated 0
Alias Born 10/06/2004

Re: ilpapa post# 184

Sunday, 09/23/2012 12:43:57 PM

Sunday, September 23, 2012 12:43:57 PM

Post# of 430
That Seeking Alpha article seems to have another agenda, IMO.

I can't argue that NVS has threats looming to its pipeline. But, it seems preposterous to me to posit that an OTC drug from a tiny company poses a serious threat to NVS in general and Diovan in particular. This article seems more a way to promote "Chromadex Corporation's (CDXC.OB) patented pTeroPure® (pterostilbene)" than downplay the NVS pipeline with any credibility.

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NVS News